B 
Bio-Techne TECH · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
72.83
+0.07%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.22bn
FY2017FY2026
Net income
$181.9m
FY2017FY2026
Free cash flow
$263.2m
FY2017FY2026
Shareholders' equity
$2.13bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22bn | $1.22bn | $1.16bn | $1.14bn | $1.11bn | $931.0m | $738.7m | $714.0m | $643.0m | $563.0m |
| Gross profit | $799.1m | $790.3m | $769.7m | $769.8m | $756.5m | $632.9m | $483.2m | $473.5m | $432.1m | $374.5m |
| Research and development | $94.8m | $99.5m | $96.7m | $92.5m | $87.1m | $70.6m | $65.2m | $62.4m | $55.3m | $53.5m |
| Operating income | $251.9m | $107.0m | $206.7m | $306.7m | $307.1m | $237.3m | $176.0m | $125.6m | $136.2m | $121.8m |
| Net income | $181.9m | $73.4m | $168.1m | $285.3m | $272.1m | $140.4m | $229.3m | $96.1m | $125.3m | $77.3m |
| Diluted earnings per share | 1.16 | 0.47 | 1.05 | 1.78 | 1.68 | 0.85 | 1.42 | 0.61 | 0.81 | 0.51 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.59bn | $2.56bn | $2.70bn | $2.64bn | $2.29bn | $2.26bn | $2.03bn | $1.88bn | $1.59bn | $1.56bn |
| Cash and short-term investments | $264.7m | $162.2m | $152.9m | $204.3m | $247.0m | $231.6m | $270.9m | $166.0m | $181.8m | $157.7m |
| Total liabilities | $457.2m | $639.1m | $635.0m | $672.2m | $593.8m | $691.7m | $646.4m | $718.8m | $514.1m | $605.8m |
| Debt | — | $346.0m | $319.0m | $350.0m | $255.9m | $341.3m | $356.7m | $505.2m | $339.0m | $343.8m |
| Shareholders' equity | $2.13bn | $1.92bn | $2.07bn | $1.97bn | $1.70bn | $1.56bn | $1.38bn | $1.17bn | $1.08bn | $950.8m |
| Shares outstanding | 157m | 157m | 161m | 160m | 162m | 165m | 161m | 158m | 155m | 152m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $292.1m | $287.6m | $299.0m | $254.4m | $325.3m | $352.2m | $205.2m | $181.6m | $170.4m | $143.4m |
| Capital spending | −$28.9m | −$31.0m | −$62.9m | −$38.2m | −$44.9m | −$44.3m | −$51.7m | −$25.4m | −$20.9m | −$15.2m |
| Free cash flow | $263.2m | $256.5m | $236.1m | $216.1m | $280.4m | $307.9m | $153.5m | $156.2m | $149.4m | $128.3m |
| Dividends paid | −$49.9m | −$50.4m | −$50.4m | −$50.3m | −$50.2m | −$49.6m | −$48.9m | −$48.4m | −$48.0m | −$47.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.2m | $311.4m | $295.9m | $286.6m | $317.0m | $316.2m | $297.0m | $289.5m |
| Gross profit | $211.4m | $208.3m | $191.3m | $188.1m | $198.8m | $214.6m | $193.9m | $183.0m |
| Operating income | $74.3m | $75.5m | $54.5m | $49.6m | −$23.9m | $38.7m | $47.4m | $41.2m |
| Net income | $54.6m | $51.1m | $38.0m | $38.2m | −$17.7m | $22.6m | $34.9m | $33.6m |
| Diluted earnings per share | 0.35 | 0.33 | 0.24 | 0.24 | -0.11 | 0.14 | 0.22 | 0.21 |
| Cash from operations | $95.0m | −$109.0m | $82.0m | $27.0m | $98.0m | $41.0m | $84.0m | $63.0m |
| Capital spending | −$8.0m | −$11.0m | −$5.0m | −$5.0m | −$4.0m | −$10.0m | −$6.0m | −$9.0m |
| Free cash flow | $87.0m | −$120.0m | $77.0m | $22.0m | $94.0m | $31.0m | $78.0m | $54.0m |
| Total assets | $2.59bn | $2.55bn | $2.52bn | $2.53bn | $2.56bn | $2.64bn | $2.67bn | $2.74bn |
| Cash and short-term investments | $264.7m | $209.8m | $172.9m | $145.0m | $162.2m | $140.7m | $177.5m | $187.5m |
| Debt | — | $214.2m | $273.7m | $313.8m | $360.1m | $344.0m | $313.5m | $313.5m |
| Shareholders' equity | $2.13bn | $2.09bn | $2.01bn | $1.97bn | $1.92bn | $2.02bn | $2.08bn | $2.14bn |
Financial ratios
Data as of 6 Oct 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% |
| Operating margin | 20.3% | 8.8% | 17.4% | 30.8% | 28.3% | 17.4% |
| Net margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% |
| Return on equity | 8.6% | 3.8% | 8.1% | 14.5% | 16.0% | 9.0% |
| Return on assets | 6.8% | 2.9% | 6.2% | 10.8% | 11.9% | 6.2% |
| Free cash flow yield | 2.8% | 2.8% | 3.1% | 2.5% | 3.2% | 3.3% |
| Revenue growth | -0.4% | 5.2% | 2.0% | 2.8% | 18.7% | 26.0% |
| Earnings growth | 147.8% | -56.3% | -41.1% | 4.9% | 93.8% | -38.8% |
| Current ratio | 4.55x | 3.46x | 3.87x | 4.84x | 3.44x | 3.35x |
| Debt to equity | 0.10x | 0.19x | 0.16x | 0.18x | 0.16x | 0.23x |
| Equity ratio | 78.7% | 75.0% | 76.5% | 74.5% | 74.2% | 69.1% |
| Interest coverage | 45.53x | 12.57x | 12.80x | 31.20x | 27.65x | 11.62x |
| R&D as a share of sales | 7.8% | 8.2% | 8.3% | 8.1% | 7.9% | 7.6% |
| Buybacks as a share of market value | -0.0% | 2.3% | -0.4% | 1.0% | 1.9% | -2.4% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.2% | 5.5% | 9.3% |
| Operating income | -6.4% | 1.2% | 5.3% |
| Net income | -13.9% | 5.3% | 5.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 65.3% | 66.1% | 66.8% | 66.7% |
| Operating margin | 14.7% | 18.4% | 20.9% | 21.4% |
| Net margin | 10.5% | 15.0% | 16.6% | 17.7% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 62.8 | 125.8 | 68.8 | 43.3 | 49.3 | 151.8 | 55.8 | 90.4 | 44.7 | 63.6 |
| Price to sales | 9.4 | 7.6 | 10.0 | 10.9 | 12.1 | 22.9 | 17.3 | 12.2 | 8.7 | 8.7 |
Market value over time
30 Nov 2016 to 5 Oct 2026, in USD
$3.95bn$11.40bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -20% | -8% | -4% | -31% | 45% | 45% | 57% | 9% | 23% | 19% |
Dividends and splits
Per share, in the currency the company pays
Paid for 18 years. Last went ex-dividend on 24 Aug 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.08 | 0.32 | 0.32 | 0.40 | 0.32 | 0.405 | 0.32 | 0.32 |
- 4-for-1 split · 30 Nov 2022
- 2-for-1 split · 4 Dec 2000
- 2-for-1 split · 18 Nov 1997
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.